Category Archives: Uncategorized

As deaths surge, WHO says too early to declare coronavirus peaking in China, elsewhere.

The News: An American citizen has died in Wuhan, China, from the coronavirus epidemic, with the death toll edging closer to the total from SARS (severe acute respiratory syndrome, circa… Read more »

2020’s health-sector IPO action is blasting off with the pricing of a China-based biggie and a bunch of new filings.

The US health-sector IPO action continues to scramble for public funding leadership. And it’s beginning with a Chinese company that raked in over $100 million. Let’s check out the action… Read more »

Gut-check alert: Don’t take your microbiome for granted. Seriously! And some gut-wrenching stock picks.

The News: Last month it was quietly reported that scientists working on the gut microbiome have discovered and isolated more than 100 completely new species of bacteria from healthy people’s… Read more »

Kaiser report says America hitting the wall as new gene-therapies rise above $1 million; “personalized” medicine looks great, but we won’t all get access to it.

The News: Posted by Kaiser Health News–on October 17, 2017 Out­rage over the high cost of can­cer care has fo­cused on sky­rock­et­ing drug prices, in­clud­ing the $475,000 price tag for the coun­try’s… Read more »

CBO clears GOP health bill for Senate; only 23 million to lose coverage this version

The News: A bill to disassemble the Affordable Care Act that passed the House by a razor-thin margin earlier this month would leave 14 million more people uninsured next year than under… Read more »

Google Parent, Sanofi to Invest $500 Million in Diabetes Joint Venture

French drugmaker Sanofi SA (Paris) and Verily, the life sciences unit of Google parent Alphabet Inc. (Mountain View CA) on Monday said they would invest about $500 million in a… Read more »

Cost of New Cholesterol Drugs Unsustainable Says JAMA Study; Ensuing Debate Rages

A new study from the University of California, San Francisco, using computer models of cardiovascular disease in American adults concludes that the price of a promising new class of cholesterol-lowering… Read more »